Sort
78,016 grants matching “breast cancer”
BUILDING A BETTER MODEL: A PERSONALIZED BREAST CANCER RISK MODEL INCORPORATING BREAST DENSITY TO STRATFY RISK AND IMPROVE APPLICATION OF RESOURCES
$1,142,712Sunnybrook Research Institute · · FY2011 · Department of Defense
GROWTH FACTOR RECEPTOR SIGNALING IN BREAST CANCER
$1,142,273University Of Texas Md Anderson Can Ctr · P01 · FY2005 · CA
Effect of Tumors on the Skeleton
$1,141,868Florent Elefteriou · Vanderbilt University · P01 · FY2009 · CA
Survey and SEER Data Collection Core
$1,141,690Nancy K Janz · University Of Michigan At Ann Arbor · P01 · FY2012 · CA
Preclinical Alzheimers Disease Drug Development of Novel MAPK Inhibitors
$1,141,669D. Martin Watterson · Northwestern University At Chicago · U01 · FY2014 · AG
PREVENTION OF BREAST CANCER AND THERAPY RESISTANCE USING NOVEL THERAPEUTIC APPROACHES
$1,141,505The University Of Texas Health Science Center At San Antonio · · FY2016 · Department of the Army
Growth Factor Receptor in Breast Cancer Progression and Metabolic Regulation
$1,140,952Mien-Chie Hung · University Of Tx Md Anderson Can Ctr · P01 · FY2011 · CA
GROWTH FACTOR RECEPTOR SIGNALING IN BREAST CANCER
$1,140,441Mien-Chie Hung · University Of Tx Md Anderson Can Ctr · P01 · FY2006 · CA
Growth Factor Receptor in Breast Cancer Progression and Metabolic Regulation
$1,140,375Mien-Chie Hung · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA
In vitro models as a window to learn how to change outcomes in women at high risk of developing breast cancer
$1,140,175Jennifer M. Rosenbluth · University Of California, San Francisco · R01 · FY2025 · CA
Signaling Pathways in Stage of Mammary Tumorigenesis
$1,139,298Boston University Medical Campus · P01 · FY2001 · ES
Effects of Intermittent Energy Restriction on Intra-Abdominal Fat and the Gut Microbiome: A Randomized Trial
$1,139,295Loic Le Marchand · University Of Hawaii At Manoa · R01 · FY2024 · CA
TGF-betas in breast cancer progression
$1,138,499Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Novel Bone-Targeting Combination Therapy for Osteosarcoma Phase II
$1,138,475Shawn Patrick Zinnen · Mbc Pharma, Inc. · R44 · FY2017 · CA
Obesity, related comorbidities, and breast cancer outcomes in African Americans
$1,138,361Elisa V Bandera · Rbhs -Cancer Institute Of New Jersey · R01 · FY2015 · CA
Hormone receptor associated epigenetic reprogramming as a mediator of environmental exposure in women's health
$1,138,304Elizabeth Martin · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells
$1,138,294Esta Sterneck · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Trial of Exercise and Lifestyle (TEAL) in Women with Ovarian Cancer
$1,138,226Melinda L Irwin · Yale University · U01 · FY2024 · CA
ONTARIO FAMILY REGISTRY FOR STUDIY OF BREAST CANCER RISK
$1,137,619Cancer Care Ontario · U01 · FY2004 · CA
Therapeutic and Diagnostic Factors as Related to Cancer Risk
$1,137,617Britton Trabert · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
SPORE in Breast Cancer
$1,137,500Joe W. Gray · University Of California, San Francisco · P50 · FY2008 · CA
Multiscale Mathematical Modeling of Cancer Progression
$1,137,478Vito Quaranta · Vanderbilt University · U54 · FY2010 · CA
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,137,453Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2017 · CA
COBRE Center for Cancer Research Development
$1,137,315Bharat Ramratnam · Rhode Island Hospital · P30 · FY2019 · GM
A genome-wide association study for breast cancer in BRCA1 mutation carriers
$1,137,311Fergus Joseph Couch · Mayo Clinic Rochester · R01 · FY2008 · CA